Stockscreener 앱 받기
1.57
5.99%
-0.10
Edap Tms S A Adr 주식(EDAP)의 최신 뉴스
EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy - Investing.com
EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy By Investing.com - Investing.com India
edap tms sa announces shareholder meeting for june 2025 By Investing.com - Investing.com India
edap tms sa announces shareholder meeting for june 2025 - Investing.com
H.C. Wainwright cuts EDAP stock price target to $14 By Investing.com - Investing.com South Africa
H.C. Wainwright cuts EDAP stock price target to $14 - Investing.com
EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting - GlobeNewswire Inc.
Focal ablation shows promise in prostate cancer trial - Investing.com
Jefferies cuts EDAP TMS stock rating, slashes target to $2 - Investing.com
Piper Sandler cuts EDAP stock price target to $4.50, keeps rating By Investing.com - Investing.com South Africa
Piper Sandler cuts EDAP stock price target to $4.50, keeps rating - Investing.com India
H.C. Wainwright maintains $19 target on EDAP TMS stock - Investing.com India
Earnings call transcript: EDAP TMS Q4 2024 sees revenue growth, stock surges - Investing.com
Allegro Microsystems Inc (ALGM) Beta Value: Understanding the Market Risk - The News Heater
EDAP TMS SA Sponsored ADR to Host Earnings Call - ACCESS Newswire
Investor Network: EDAP TMS SA Sponsored ADR to Host Earnings Call - ACCESS Newswire
EDAP initiates trial for pancreatic cancer treatment - Investing.com India
Earnings call: EDAP TMS sees growth with Focal One HIFU business - Investing.com
EDAP's Avenda Deal For AI-Assisted Cancer Care Likely To Drive Stock - Barchart.com
Biotech & Pharma News, Stocks, FDA Decision, Clinical Trials - RTTNews
Perkins Capital Raises Exposure in EDAP TMS - Insider Monkey
Friday's Top Biotech and Medical Stocks - 24/7 Wall St.
1.13%
8.94%
자본화:
|
볼륨(24시간):